ÂÜÀòÂÒÂ×

Ashley joined Zomedica in 2019 to facilitate the development of BAW technology for use in veterinary medicine. She now leads the company’s research and development activities. Ashley’s expertise is in the areas of molecular biology, cell biology, imaging techniques, and biochemistry.

Prior to her current role, Ashley was part of the R&D group at Swift Biosciences, where she was responsible for creating market viable products as the lead scientist in the advancement of next-generation sequencing assays. Her responsibilities included assay development, bioinformatic analysis, and transfer to manufacturing.

Ashley also served as a research assistant professor and completed a postdoctoral research fellowship (awarded by the American Cancer Society) in the Cell & Molecular Biology department at Northwestern University’s Feinberg School of Medicine. She has co-authored several papers that have appeared in industry-prominent journals.

Ashley graduated with honors from Duke University with a degree in biochemistry and earned a Ph.D. in molecular biology from Johns Hopkins University.